These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 13699823)

  • 21. [A new neuroleptic with delayed hypnogenic effect: dipiperon (R3345), butyrophenone carbamide].
    BOBON J; COLLARD J; DEMARET A
    Acta Neurol Psychiatr Belg; 1961 Jul; 61():611-30. PubMed ID: 13870300
    [No Abstract]   [Full Text] [Related]  

  • 22. [Ist results in the use, in psychiatric therapy, of a new neuroleptic drug: thioidazine (Melleril)].
    CASI A; LOMBARDI M; MARZOTTI P
    Rass Studi Psichiatr; 1961; 50():472-80. PubMed ID: 13691284
    [No Abstract]   [Full Text] [Related]  

  • 23. [Some clinical observations on derivatives of thioxanthene and of benzoquinolizine in psychiatry].
    de CAMPOS JS; PINTO OF
    Hospital (Rio J); 1961 Feb; 59():367-74. PubMed ID: 13690321
    [No Abstract]   [Full Text] [Related]  

  • 24. Fluorophenothiazine-238A, a new and more potent neuroleptic agent.
    ROBINSON J; McCABE ES; YEE R
    Del State Med J; 1960 Oct; 32():388-92. PubMed ID: 13742300
    [No Abstract]   [Full Text] [Related]  

  • 25. Permitil. An evaluation of its use in psychiatric outpatients.
    FLAHERTY JA
    Del Med J; 1961 Aug; 33():217-24. PubMed ID: 13700108
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experiences with Truxal in institutional practice].
    ANTON A
    Med Welt; 1961 Jun; 22():1221-3. PubMed ID: 13683751
    [No Abstract]   [Full Text] [Related]  

  • 27. The use and abuse of tranquilizing drugs.
    PROCTOR RC
    J Tn State Med Assoc; 1960 Jul; 53():295-9. PubMed ID: 14435008
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical trials with thioridazine in maladjusted children of school age].
    RENARD P; BONJAC M; BARRE L
    Ann Med Psychol (Paris); 1962 Mar; 120(1)():578-86. PubMed ID: 14491442
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical investigation of levomepromazine (nozinan) in open psychiatric settings.
    SARWER-FONER GJ; HAJNSEK F; GROSZMAN M; GRAUER H; KORANYI EK
    Med Serv J Can; 1961 Dec; 17():798-817. PubMed ID: 14497301
    [No Abstract]   [Full Text] [Related]  

  • 30. Experience with chemotherapy in refractory psychiatric disorders.
    PIGNATARO FP
    Curr Ther Res Clin Exp; 1962 Aug; 4():389-98. PubMed ID: 14486577
    [No Abstract]   [Full Text] [Related]  

  • 31. [Remarks concerning the medicinal ambulatory treatment of psychic disorders].
    SCHNEIDER PB
    Bull Schweiz Akad Med Wiss; 1959 Sep; 15():296-307. PubMed ID: 14443244
    [No Abstract]   [Full Text] [Related]  

  • 32. Tranquilizers: their use and abuse.
    CONWAY CF
    Trans Stud Coll Physicians Phila; 1960 Jul; 28():38-45. PubMed ID: 13811653
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical trial of prothipendyl in child neuropsychiatry].
    MICHAUX L; DUCHE DJ; PRINGUET G
    Rev Neuropsychiatr Infant; 1962; 10():139-58. PubMed ID: 14473383
    [No Abstract]   [Full Text] [Related]  

  • 34. The use of psychopharmacologic agents in retarded children with behavior disorders.
    LAVECK GD; BUCKLEY P
    J Chronic Dis; 1961 Feb; 13():174-83. PubMed ID: 13759602
    [No Abstract]   [Full Text] [Related]  

  • 35. [Critical notes on the use and abuse of anti-anxiety drugs].
    SACERDOTI G
    Riv Sper Freniatr Med Leg Alien Ment; 1959 Jun; 83():668-84. PubMed ID: 14440597
    [No Abstract]   [Full Text] [Related]  

  • 36. Mellaril in the treatment of the geriatric patient.
    JACKSON EB
    Am J Psychiatry; 1961 Dec; 118():543-4. PubMed ID: 14450583
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical evaluation of trifluoperazine in maximum-security brain-damaged patients with severe behavioral disorders.
    VASCONCELLOS J
    J Clin Exp Psychopathol Q Rev Psychiatry Neurol; 1960; 21():25-30. PubMed ID: 13841393
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of mephenoxalone in behavioral problems.
    KRAFT IA
    Am J Psychiatry; 1962 Mar; 118():841-2. PubMed ID: 14459221
    [No Abstract]   [Full Text] [Related]  

  • 39. [Psychostabilization as a factor in prevention of mental risk in industry].
    BALLANDRAS AJ
    Dia Med; 1962 Jul; 34():1222-4. PubMed ID: 13864423
    [No Abstract]   [Full Text] [Related]  

  • 40. [Note on certain tests used in the objective control of the psychological effects of therapeutics in psychiatry. Applications to neuroleptic treatments].
    RISER M; HURON R; GAYRAL L; CARRIE J; BENAZET J; VELUT R
    Therapie; 1960; 15():940-6. PubMed ID: 13741841
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.